CTI BioPharma soars on deal news, while Upstart and Rivian climb after earnings

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

CTI Biotech, Upstart, RingCentral, Twilio and H&R Block were among some of Wednesday's biggest moving stocks in premarket trading.

CTI BioPharma Corp. CTIC stock soared 83% in premarket trading after Swedish Orphan Biovitrum AB SE:SOBI said it had entered into an agreement to acquire the biotech in a deal valued at $1.7 billion. The offer represents a premium of 88.8% over CTI’s... Here are some of the biggest stock moves in premarket action on Wednesday:CTI BioPharma Corp.

Shares of IAC Inc. IAC climbed nearly 9% after the internet and media holding company posted sales of $1.08 billion, down 18% from a year ago but eclipsing analyst estimates of $1.06 billion. Toast Inc. TOST shares rose 4% after the restaurant-industry software provider reported a beat-and-raise quarter.

Shares of H&R Block Inc. HRB fell 8% after the tax-preparation company slashed its outlook for the full fiscal year, blaming a tax season that didn’t pan out according to expectations.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 3. in PT
 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Upstart stock soars as earnings outlook positively surprisesShares of Upstart were rocketing 27% in after-hours trading Tuesday after the financial-services company delivered an upbeat outlook for the current period.
Fonte: MarketWatch - 🏆 3. / 97 Consulte Mais informação »

Baxter to divest biopharma business for $4.25 billionBaxter International Inc said on Monday a private-equity group, which includes Warburg Pincus and Advent International, has agreed to buy its biopharma solutions unit for $4.25 billion.
Fonte: Reuters - 🏆 2. / 97 Consulte Mais informação »